Convergence Financial, LLC Novo Nordisk A S Transaction History
Convergence Financial, LLC
- $501 Billion
- Q4 2024
A detailed history of Convergence Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Convergence Financial, LLC holds 11,554 shares of NVO stock, worth $912,766. This represents 0.2% of its overall portfolio holdings.
Number of Shares
11,554
Previous 11,151
3.61%
Holding current value
$912,766
Previous $1.33 Billion
25.15%
% of portfolio
0.2%
Previous 0.28%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,885Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.58 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.22 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.03 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$999 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$964 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $178B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...